Screening for mobility problems in people with several long-term illnesses
Tests a screening method to identify mobility problems in adults with chronic illness.
Plain-language title generated from the registry record
Registry title: Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Key facts
- Where
- Clermont-Ferrand, FranceSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a long-term illness that makes moving around harder. It aims to describe a typical profile of reduced mobility.
- Age
- 18 to 90 years
- Sex
- Men and women
- Disease stage
- A long-term (chronic) illness that contributes to impaired mobility. The conditions listed are joint osteoarthritis, atherosclerosis of the distal arteries, Parkinson disease, COPD and obesity.
Main reasons for not taking part
- Active psychiatric illness (active psychosis, hallucinations) or another serious unstable illness
- Poorly controlled or unstable heart and blood vessel disease
- Major bone, joint or nerve problems that fully prevent doing the tests
- Not independent (non-autonomous)
- Pregnant or breastfeeding women
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT04375280, who can take part
Where in France
- CHU Clermont-FerrandClermont-Ferrand, FranceContact: Lise LaclautreTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University Hospital, Clermont-Ferrand
- Trial code
- NCT04375280
- Record updated
- 4 November 2026
- Original description
Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern. Therefore, the exploration of locomotor deficiencies, physical capacities and metabolism of patients with chronic illnesses constitutes a major challenge both for the treatment of causal pathologies, as well as for evaluating the impact of therapeutic interventions, the benefit of which will be an improvement in physical capacities and ultimately mobility. In view of the hypothesis of an increase in the prevalence of mobility disorders in this population, this approach is part of a logic of screening and improving the effectiveness of the care of these patients with a multidisciplinary evaluation of individual risks. The EVALMOB protocol was designed in order to try to determine a standard profile of "dysmobility" in patients with chronic illnessRead full original descriptionShow less
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Chronic illness is a public health issue and mobility loss is frequent in this population. Among its' multiple physical and psychological consequences, increased mortality and cardiovascular morbidity seem the main concern. Therefore, the exploration of locomotor deficiencies, physical capacities and metabolism of patients with chronic illnesses constitutes a major challenge both for the treatment of causal pathologies, as well as for evaluating the impact of therapeutic interventions, the benefit of which will be an improvement in physical capacities and ultimately mobility. In view of the hypothesis of an increase in the prevalence of mobility disorders in this population, this approach is part of a logic of screening and improving the effectiveness of the care of these patients with a multidisciplinary evaluation of individual risks. The EVALMOB protocol was designed in order to try to determine a standard profile of "dysmobility" in patients with chronic illness
Inclusion: Man or woman aged 18 to 90; Patients with chronic pathology contributing to impaired mobility; Volunteers who have given their written consent; Affiliated to French health care system (for France).
Exclusion: Patients suffering from progressive psychiatric pathologies (active psychosis, hallucinations, etc.) or the presence of another serious unstabilized pathology (decompensated heart failure, progressive terminal cancer, etc.); People with poorly controlled or unstable cardiovascular disease; Major osteoarticular or neurological problems completely preventing the proper performance of the various tests; Non-autonomous patient; Persons under guardianship, curatorship, deprived of liberty or safeguarding justice; People excluded from another study; Pregnant or lactating women.